Population-level estimates of hepatitis C reinfection post scale-up of direct-acting antivirals among people who inject drugs.

导出 OA

翻译打印收藏纠错

作者： Alan,Yeung ^[1] ; Norah E,Palmateer ^[2] ; John F,Dillon ^[3] ; Scott A,McDonald ^[2] ; Shanley,Smith ^[2] ; Stephen,Barclay ^[4] ; Peter C,Hayes ^[5] ; Rory N,Gunson ^[6] ; Kate,Templeton ^[7] ; David J,Goldberg ^[8] ; Matthew,Hickman ^[9] ; Sharon J,Hutchinson ^[2]

作者单位： Glasgow Caledonian University, Glasgow, United Kingdom; Public Health Scotland, Edinburgh, United Kingdom. Electronic address: alan.yeung@gcu.ac.uk. ^[1] Glasgow Caledonian University, Glasgow, United Kingdom; Public Health Scotland, Edinburgh, United Kingdom. ^[2] University of Dundee, Dundee, United Kingdom. ^[3] Glasgow Royal Infirmary, Glasgow, United Kingdom. ^[4] Royal Infirmary of Edinburgh, Edinburgh, United Kingdom. ^[5] West of Scotland Specialist Virology Centre, Glasgow Royal Infirmary, Glasgow, United Kingdom. ^[6] Royal Infirmary of Edinburgh, Specialist Virology Centre, Edinburgh, United Kingdom. ^[7] Public Health Scotland, Edinburgh, United Kingdom; Glasgow Caledonian University, Glasgow, United Kingdom. ^[8] Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom; NIHR Health Protection Research Unit in Behavioural Science and Evaluation, Bristol, United Kingdom. ^[9]

关键词 HCV Incidence Injecting PWID Reinfection SVR Sustained virological response